Human metabolic individuality in biomedical and pharmaceutical research.

PubWeight™: 6.56‹?› | Rank: Top 1%

🔗 View Article (PMC 3832838)

Published in Nature on August 31, 2011

Authors

Karsten Suhre1,2,3, So-Youn Shin4, Ann-Kristin Petersen5, Robert P Mohney6, David Meredith7, Brigitte Wägele1,8, Elisabeth Altmaier1, CARDIoGRAM, Panos Deloukas4, Jeanette Erdmann9, Elin Grundberg4,10, Christopher J Hammond10, Martin Hrabé de Angelis11,12, Gabi Kastenmüller1, Anna Köttgen13, Florian Kronenberg14, Massimo Mangino10, Christa Meisinger15, Thomas Meitinger16,17, Hans-Werner Mewes1,8, Michael V Milburn6, Cornelia Prehn11, Johannes Raffler1,2, Janina S Ried4, Werner Römisch-Margl1, Nilesh J Samani18, Kerrin S Small10, H-Erich Wichmann19,20,21, Guangju Zhai10, Thomas Illig22, Tim D Spector10, Jerzy Adamski11, Nicole Soranzo4, Christian Gieger5

Author Affiliations

1: Institute of Bioinformatics and Systems Biology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
2: Faculty of Biology, Ludwig-Maximilians-Universität, Planegg-Martinsried, Germany.
3: Department of Physiology and Biophysics, Weill Cornell Medical College in Qatar, Education City - Qatar Foundation, Doha, Qatar.
4: The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton UK.
5: Institute of Genetic Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
6: Metabolon Inc., Durham, North Carolina, USA.
7: School of Life Sciences, Oxford Brookes University, Headington, Oxford, UK.
8: Department of Genome-oriented Bioinformatics, Life and Food Science Center Weihenstephan, Technische Universität München, Freising-Weihenstephan, Germany.
9: Universität zu Lübeck, Medizinische Klinik II, Lübeck, Germany.
10: Department of Twin Research & Genetic Epidemiology, King's College London, UK.
11: Institute of Experimental Genetics, Genome Analysis Center, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
12: Institute of Experimental Genetics, Life and Food Science Center Weihenstephan, Technische Universität München, Freising-Weihenstephan, Germany.
13: Renal Division, University Hospital Freiburg, Germany.
14: Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Innsbruck, Austria.
15: Institute of Epidemiology II, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
16: Institute of Human Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
17: Institute of Human Genetics, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
18: Department of Cardiovascular Sciences, University of Leicester, and Leicester NIHR Biomedical Research Unit in Cardiovascular Disease, Glenfield Hospital, Leicester, UK.
19: Institute of Epidemiology I, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
20: Institute of Medical Informatics, Biometry and Epidemiology, Chair of Epidemiology, Ludwig-Maximilians-Universität, Munich, Germany.
21: Klinikum Grosshadern, Munich, Germany.
22: Unit for Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.

Articles citing this

(truncated to the top 100)

Innovation: Metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol (2012) 5.19

Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet (2012) 4.08

An atlas of genetic influences on human blood metabolites. Nat Genet (2014) 3.21

Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04

Cellular metabolism and disease: what do metabolic outliers teach us? Cell (2012) 2.90

Pharmacogenomics and individualized medicine: translating science into practice. Clin Pharmacol Ther (2012) 2.48

Cohort Profile: TwinsUK and healthy ageing twin study. Int J Epidemiol (2012) 2.37

2-Aminoadipic acid is a biomarker for diabetes risk. J Clin Invest (2013) 2.15

Genetics of osteoporosis from genome-wide association studies: advances and challenges. Nat Rev Genet (2012) 2.07

The human circadian metabolome. Proc Natl Acad Sci U S A (2012) 2.04

Systems genetics approaches to understand complex traits. Nat Rev Genet (2013) 1.97

Novel Loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis. PLoS Genet (2012) 1.97

The UK Adult Twin Registry (TwinsUK Resource). Twin Res Hum Genet (2012) 1.81

Metabolic signatures of insulin resistance in 7,098 young adults. Diabetes (2012) 1.80

Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. Circulation (2012) 1.64

Acylcarnitines: reflecting or inflicting insulin resistance? Diabetes (2013) 1.54

Metabolomics in epidemiology: sources of variability in metabolite measurements and implications. Cancer Epidemiol Biomarkers Prev (2013) 1.50

A genome-wide pleiotropy scan for prostate cancer risk. Eur Urol (2014) 1.48

Metabolomic markers reveal novel pathways of ageing and early development in human populations. Int J Epidemiol (2013) 1.48

Plasma metabolomic profiles enhance precision medicine for volunteers of normal health. Proc Natl Acad Sci U S A (2015) 1.41

Mining the unknown: a systems approach to metabolite identification combining genetic and metabolic information. PLoS Genet (2012) 1.41

Value of biomarkers in osteoarthritis: current status and perspectives. Ann Rheum Dis (2013) 1.40

Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms. Cell (2017) 1.38

Defects in muscle branched-chain amino acid oxidation contribute to impaired lipid metabolism. Mol Metab (2016) 1.38

Metabolic signature of CKD: the search continues. Am J Kidney Dis (2012) 1.38

Genetic variation in metabolic phenotypes: study designs and applications. Nat Rev Genet (2012) 1.38

Effect of Insulin Resistance on Monounsaturated Fatty Acid Levels: A Multi-cohort Non-targeted Metabolomics and Mendelian Randomization Study. PLoS Genet (2016) 1.38

Reproducibility of metabolomic profiles among men and women in 2 large cohort studies. Clin Chem (2013) 1.37

HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Res (2015) 1.36

Metabolomics and cardiovascular biomarker discovery. Clin Chem (2011) 1.36

Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease. Mol Cell Proteomics (2012) 1.36

Metabolomics in nutritional epidemiology: identifying metabolites associated with diet and quantifying their potential to uncover diet-disease relations in populations. Am J Clin Nutr (2014) 1.35

A genome-wide association study of the human metabolome in a community-based cohort. Cell Metab (2013) 1.33

Ischemic stroke is associated with the ABO locus: the EuroCLOT study. Ann Neurol (2013) 1.30

Sherlock: detecting gene-disease associations by matching patterns of expression QTL and GWAS. Am J Hum Genet (2013) 1.29

Multivariate phenotype association analysis by marker-set kernel machine regression. Genet Epidemiol (2012) 1.29

OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin. Proc Natl Acad Sci U S A (2014) 1.24

Epigenetics meets metabolomics: an epigenome-wide association study with blood serum metabolic traits. Hum Mol Genet (2013) 1.23

Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes. JAMA (2013) 1.22

Role of plasma kallikrein in diabetes and metabolism. Thromb Haemost (2013) 1.22

A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control. Elife (2013) 1.19

Genetics of type 2 diabetes-pitfalls and possibilities. Genes (Basel) (2015) 1.16

Emerging applications of metabolomics in drug discovery and precision medicine. Nat Rev Drug Discov (2016) 1.14

Targeted metabolomics profiles are strongly correlated with nutritional patterns in women. Metabolomics (2012) 1.13

The emerging paradigm of network medicine in the study of human disease. Circ Res (2012) 1.12

Histone Methylation Dynamics and Gene Regulation Occur through the Sensing of One-Carbon Metabolism. Cell Metab (2015) 1.11

GLiMMPS: robust statistical model for regulatory variation of alternative splicing using RNA-seq data. Genome Biol (2013) 1.11

Genetic and epigenetic regulation of gene expression in fetal and adult human livers. BMC Genomics (2014) 1.09

Analytical methods in untargeted metabolomics: state of the art in 2015. Front Bioeng Biotechnol (2015) 1.08

Pharmacogenomics of Cytochrome P450 3A4: Recent Progress Toward the "Missing Heritability" Problem. Front Genet (2013) 1.07

An integrated epigenomic analysis for type 2 diabetes susceptibility loci in monozygotic twins. Nat Commun (2014) 1.06

Genetic variants associated with glycine metabolism and their role in insulin sensitivity and type 2 diabetes. Diabetes (2013) 1.06

Phenome-wide association study (PheWAS) in EMR-linked pediatric cohorts, genetically links PLCL1 to speech language development and IL5-IL13 to Eosinophilic Esophagitis. Front Genet (2014) 1.06

Genetic analysis of the metabolome exemplified using a rice population. Proc Natl Acad Sci U S A (2013) 1.04

Diving through the "-omics": the case for deep phenotyping and systems epidemiology. OMICS (2012) 1.03

Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery. Drug Discov Today (2013) 1.03

Correlation of rare coding variants in the gene encoding human glucokinase regulatory protein with phenotypic, cellular, and kinetic outcomes. J Clin Invest (2011) 1.03

Factor structure underlying components of allostatic load. PLoS One (2012) 1.03

Molecular phenotyping of a UK population: defining the human serum metabolome. Metabolomics (2014) 1.02

Translational regulation shapes the molecular landscape of complex disease phenotypes. Nat Commun (2015) 1.02

Toward new biomarkers of cardiometabolic diseases. Cell Metab (2013) 1.02

Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism. Eur J Epidemiol (2014) 1.01

Pleiotropic genes for metabolic syndrome and inflammation. Mol Genet Metab (2014) 1.01

r2VIM: A new variable selection method for random forests in genome-wide association studies. BioData Min (2016) 1.01

Network medicine approaches to the genetics of complex diseases. Discov Med (2012) 1.00

Addressing human variability in next-generation human health risk assessments of environmental chemicals. Environ Health Perspect (2012) 1.00

Statistical methods for the analysis of high-throughput metabolomics data. Comput Struct Biotechnol J (2013) 1.00

Effects of age, sex, and genotype on high-sensitivity metabolomic profiles in the fruit fly, Drosophila melanogaster. Aging Cell (2014) 0.99

Personalized genomic disease risk of volunteers. Proc Natl Acad Sci U S A (2013) 0.99

On the hypothesis-free testing of metabolite ratios in genome-wide and metabolome-wide association studies. BMC Bioinformatics (2012) 0.99

Structuring research methods and data with the research object model: genomics workflows as a case study. J Biomed Semantics (2014) 0.98

Markers of endogenous desaturase activity and risk of coronary heart disease in the CAREMA cohort study. PLoS One (2012) 0.98

GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence. Diabetologia (2014) 0.97

Adolescent idiopathic scoliosis (AIS), environment, exposome and epigenetics: a molecular perspective of postnatal normal spinal growth and the etiopathogenesis of AIS with consideration of a network approach and possible implications for medical therapy. Scoliosis (2011) 0.97

Cellular genomics for complex traits. Nat Rev Genet (2012) 0.97

Large-scale metabolomic profiling identifies novel biomarkers for incident coronary heart disease. PLoS Genet (2014) 0.97

Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine. World J Gastroenterol (2015) 0.96

Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease. Transl Psychiatry (2015) 0.96

Genetic regulation of mouse liver metabolite levels. Mol Syst Biol (2014) 0.95

The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression. Mol Psychiatry (2013) 0.95

Genetic determinants influencing human serum metabolome among African Americans. PLoS Genet (2014) 0.95

Insight in genome-wide association of metabolite quantitative traits by exome sequence analyses. PLoS Genet (2015) 0.94

Genome-wide association study identifies novel genetic variants contributing to variation in blood metabolite levels. Nat Commun (2015) 0.93

Metabolomics enables precision medicine: "A White Paper, Community Perspective". Metabolomics (2016) 0.93

Development and validation of a robust automated analysis of plasma phospholipid fatty acids for metabolic phenotyping of large epidemiological studies. Genome Med (2013) 0.93

Metabolomic analysis of key regulatory metabolites in hepatitis C virus-infected tree shrews. Mol Cell Proteomics (2012) 0.92

Metabolomics in pneumonia and sepsis: an analysis of the GenIMS cohort study. Intensive Care Med (2013) 0.91

Genome-wide association study of metabolic traits reveals novel gene-metabolite-disease links. PLoS Genet (2014) 0.91

Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene. J Clin Invest (2015) 0.90

Analyzing and mapping sweat metabolomics by high-resolution NMR spectroscopy. PLoS One (2011) 0.89

Genome-wide association study of a heart failure related metabolomic profile among African Americans in the Atherosclerosis Risk in Communities (ARIC) study. Genet Epidemiol (2013) 0.89

Neuroinflammation and comorbidities are frequently ignored factors in CNS pathology. Neural Regen Res (2015) 0.89

Acylcarnitines--old actors auditioning for new roles in metabolic physiology. Nat Rev Endocrinol (2015) 0.89

Serum biomarkers of habitual coffee consumption may provide insight into the mechanism underlying the association between coffee consumption and colorectal cancer. Am J Clin Nutr (2015) 0.88

Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. Nat Commun (2016) 0.88

Identification and MS-assisted interpretation of genetically influenced NMR signals in human plasma. Genome Med (2013) 0.88

Genetics of human metabolism: an update. Hum Mol Genet (2015) 0.87

Association between gout and polymorphisms in GCKR in male Han Chinese. Hum Genet (2012) 0.86

A genome-wide association study of saturated, mono- and polyunsaturated red blood cell fatty acids in the Framingham Heart Offspring Study. Prostaglandins Leukot Essent Fatty Acids (2014) 0.86

Differences in metabolomic and transcriptomic profiles between responders and non-responders to an n-3 polyunsaturated fatty acids (PUFAs) supplementation. Genes Nutr (2012) 0.86

Articles cited by this

PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92

Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A (2009) 54.68

Merlin--rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet (2001) 53.16

A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet (2009) 30.09

Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature (2009) 12.58

Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet (2008) 12.32

SLCO1B1 variants and statin-induced myopathy--a genomewide study. N Engl J Med (2008) 11.31

Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet (2009) 8.39

A genotype calling algorithm for the Illumina BeadArray platform. Bioinformatics (2007) 8.03

KORA-gen--resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen (2005) 7.93

Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet (2008) 7.05

Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem (2009) 6.43

A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet (2009) 6.31

Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base. Pharmacogenomics J (2001) 5.94

New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58

Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet (2008) 5.23

A genome-wide perspective of genetic variation in human metabolism. Nat Genet (2009) 5.00

Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet (2009) 4.97

Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet (2008) 4.69

SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet (2008) 4.67

Are twins and singletons comparable? A study of disease-related and lifestyle characteristics in adult women. Twin Res (2001) 4.50

A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. Proc Natl Acad Sci U S A (2007) 4.35

Meta-analysis of genome-wide scans for human adult stature identifies novel Loci and associations with measures of skeletal frame size. PLoS Genet (2009) 4.24

Genetic loci influencing kidney function and chronic kidney disease. Nat Genet (2010) 3.75

Analysis of the adult human plasma metabolome. Pharmacogenomics (2008) 3.74

SLC2A9 is a high-capacity urate transporter in humans. PLoS Med (2008) 2.87

Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One (2010) 2.84

Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics. Clin Pharmacol Ther (2007) 2.80

Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood (2009) 2.64

Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats. Toxicol Pathol (2009) 2.16

Genome-wide association meta-analysis for total serum bilirubin levels. Hum Mol Genet (2009) 1.96

The SLC22 drug transporter family. Pflugers Arch (2003) 1.95

Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia. Hum Mol Genet (2009) 1.87

Bioinformatics analysis of targeted metabolomics--uncovering old and new tales of diabetic mice under medication. Endocrinology (2008) 1.75

Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin. Pharmacogenet Genomics (2009) 1.46

Eight common genetic variants associated with serum DHEAS levels suggest a key role in ageing mechanisms. PLoS Genet (2011) 1.30

A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform. Pharmacogenomics J (2009) 1.18

Gilbert's Syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk. Cancer Epidemiol Biomarkers Prev (2008) 1.10

Hepatic glycogen breakdown is implicated in the maintenance of plasma mannose concentration. Am J Physiol Endocrinol Metab (2004) 1.10

The SLC16 monocaboxylate transporter family. Xenobiotica (2008) 1.09

Site-directed mutation of arginine 282 to glutamate uncouples the movement of peptides and protons by the rabbit proton-peptide cotransporter PepT1. J Biol Chem (2004) 1.08

Getting biological about the genetics of diabetes. Nat Med (2010) 1.05

AKR1C isoforms represent a novel cellular target for jasmonates alongside their mitochondrial-mediated effects. Cancer Res (2009) 1.04

Inborn variation in metabolism. Nat Genet (2010) 1.01

Mannose enters mammalian cells using a specific transporter that is insensitive to glucose. J Biol Chem (1996) 0.99

Amino-acid sequence and the occurrence of phosphorus in human fibrinopeptides. Nature (1962) 0.98

Increased phosphate content of fibrinogen in vivo correlates with alteration in fibrinogen behaviour. Thromb Res (1992) 0.88

Articles by these authors

Dysfunctional nitric oxide signalling increases risk of myocardial infarction. Nature (2013) 2.24

Intravenous iron administration: new observations and time for the next steps. Kidney Int (2015) 2.02

Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature (2016) 1.59

Glycated hemoglobin and risk of death in diabetic patients treated with hemodialysis: a meta-analysis. Am J Kidney Dis (2013) 1.56

Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community. J Am Heart Assoc (2015) 0.96

Genetic predisposition to higher blood pressure increases coronary artery disease risk. Hypertension (2013) 0.95

Variation in the human lipidome associated with coffee consumption as revealed by quantitative targeted metabolomics. Mol Nutr Food Res (2009) 0.94

Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort. Nephrol Dial Transplant (2014) 0.88

Metabolite profiling reveals new insights into the regulation of serum urate in humans. Metabolomics (2013) 0.87

Genetic determinants of circulating interleukin-1 receptor antagonist levels and their association with glycemic traits. Diabetes (2014) 0.86

Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes. J Allergy Clin Immunol (2015) 0.85

Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes. Diabetes (2015) 0.85

Genome-Wide Association Study with Targeted and Non-targeted NMR Metabolomics Identifies 15 Novel Loci of Urinary Human Metabolic Individuality. PLoS Genet (2015) 0.84

Gender-specific pathway differences in the human serum metabolome. Metabolomics (2015) 0.83

Psoriasis and cardiometabolic traits: modest association but distinct genetic architectures. J Invest Dermatol (2015) 0.83

Lipoprotein(a): there's life in the old dog yet. Circulation (2014) 0.82

Differential association between biomarkers of subclinical inflammation and painful polyneuropathy: results from the KORA F4 study. Diabetes Care (2014) 0.82

Iron supplementation and mortality in incident dialysis patients: an observational study. PLoS One (2014) 0.80

Modifying effect of a common polymorphism in the interleukin-6 promoter on the relationship between long-term exposure to traffic-related particulate matter and heart rate variability. PLoS One (2014) 0.80

Adverse conditions at the workplace are associated with increased suicide risk. J Psychiatr Res (2014) 0.80

Room for depressed and exhausted mood as a risk predictor for all-cause and cardiovascular mortality beyond the contribution of the classical somatic risk factors in men. Atherosclerosis (2016) 0.78

Metabolic switch during adipogenesis: From branched chain amino acid catabolism to lipid synthesis. Arch Biochem Biophys (2015) 0.78

Identification of novel biomarkers for Parkinson's disease by metabolomic technologies. J Neurol Neurosurg Psychiatry (2015) 0.78

A systematic evaluation of short tandem repeats in lipid candidate genes: riding on the SNP-wave. PLoS One (2014) 0.77

A Low-Frequency Inactivating Akt2 Variant Enriched in the Finnish Population is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk. Diabetes (2017) 0.75

A functional variant in NEPH3 gene confers high risk of renal failure in primary hematuric glomerulopathies. Evidence for predisposition to microalbuminuria in the general population. PLoS One (2017) 0.75

Specific Metabolic Markers Are Associated with Future Waist-Gaining Phenotype in Women. PLoS One (2016) 0.75

Genome wide meta-analysis highlights the role of genetic variation in RARRES2 in the regulation of circulating serum chemerin. PLoS Genet (2014) 0.75

Characterization of the metabolic profile associated with serum 25-hydroxyvitamin D: a cross-sectional analysis in population-based data. Int J Epidemiol (2016) 0.75

Cardiovascular Risk Factors Associated with Blood Metabolite Concentrations and Their Alterations over a 4-Year Period in a Population-Based Cohort. Circ Cardiovasc Genet (2016) 0.75

Metabolite ratios as potential biomarkers for type 2 diabetes: a DIRECT study. Diabetologia (2017) 0.75

Automated pathway and reaction prediction facilitates in silico identification of unknown metabolites in human cohort studies. J Chromatogr B Analyt Technol Biomed Life Sci (2017) 0.75

Non-targeted metabolomics combined with genetic analyses identifies bile acid synthesis and phospholipid metabolism as being associated with incident type 2 diabetes. Diabetologia (2016) 0.75

Comprehensive metabolic characterization of serum osteocalcin action in a large non-diabetic sample. PLoS One (2017) 0.75

Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study. J Am Coll Cardiol (2016) 0.75